Eric Kastango, MBA, RPh, is Now Profiled at the Expert Information for Journalists Website
Eric Kastango, president and CEO of Clinical IQ and frequent consultant to Baxa Corporation on hospital pharmacy safety issues is now profiled on the Expert Information For Journalists Web site – Expert411.com. Baxa Corp., a privately held company, is a leader in serving hospital pharmacy systems for handling, packaging and administering liquid medications from oral to multi-ingredient IV. Baxa is a registered medical device manufacturer with the FDA and has sales in more than 35 countries.
Denver, CO, December 07, 2006 --(PR.com)-- Eric Kastango, MBA, RPh, president and CEO of Clinical IQ and frequent consultant to Baxa Corporation on hospital pharmacy safety issues, is now profiled on the Expert Information For Journalists website – http://expert411.com/_wsn/page14.html . He is prepared to address topics related to hospital pharamcy safety for media interviews and backgrounding purposes.
Kastango is a Fellow of the American Society of Health-System Pharmacists and has served on the ASHP's Council of Education Affairs and as a pharmacy surveyor for the Accreditation Commission for Health Care, Inc. (ACHC). He travels across the United States to make professional presentations on a variety of pharmacy practice topics, including USP General Chapter 797 compliance, sterile preparation and pharmacy compounding errors, quality systems and collaborative pharmacy/nursing practice models. Kastango also is an elected member of the United States Pharmacopeia Council of Experts (Sterile Compounding Committee).
Kastango’s company Clinical IQ is a sponsor of the new state-of-the-art STAR (Skills Training, Academics and Resources) Center for pharmacy and cleanroom skills training on the Baxa Corporation campus. Baxa designed and built the STAR Center as a fully USP 797-compliant pharmacy cleanroom to provide professional education on pharmacy practice, cleanroom principles and compliance to regulatory requirements.
The STAR Center, the only dedicated facility of its kind in the world for hands-on cleanroom experience and training in environmental monitoring and aseptic technique, provides a unique opportunity for industry professionals to learn best practice from subject-matter expert trainers. More information is available at http://www.baxa.com/starcenter
On the subject of USP 797, Baxa Corporation has the technical paper, “Understanding USP 797,” available at http://www.publicrelationsnewsroom.com/_wsn/page4.html . In addition, the case study, “USP 797 Training Requirements,” is accessible at http://www.publicrelationsnewsroom.com/_wsn/page17.html
During the past year, Baxa Corporation and Kastango collaborated on the educational CD, 'What’s Next For USP 797?' – an educational CD produced as a public service for hospital pharmacists and administrators. Kastango’s presentation was originally recorded as a presentation to the annual American Society of Health-System Pharmacists (ASHP). The CD is aimed to help pharmacy directors and operational managers better understand the requirements for meeting the environmental controls outlined for sterile compounding under the new Chapter. It includes a discussion of current state for pharmacy compliance and the necessary next steps in moving from gap analysis to action plan for addressing the pharmacy changes to comply with USP 797.
A complimentary copy of the CD is available by calling 800.567.BAXA (2292) and submitting your name, title, organization affiliation and mailing address information.
Additional links of interest include:
Eric Kastango podcast about the educational CD:
http://301url.com/EricKPodcast
Link to ASHP Guidelines on Handling Hazardous Drugs: http://www.ashp.org/bestpractices/new/Haz_AJHP.pdf
About Baxa Corporation
Baxa, a customer-focused medical device company, provides innovative, solution-based technologies for fluid handling and delivery. Its systems and devices promote the safe and efficient preparation, handling, packaging, and administration of fluid medications. Key products include Rapid-Fill™ Automated Syringe Fillers, Exacta-Med® Oral Dispensers, MicroFuse® Syringe Infusers, Repeater™ Pharmacy Pumps, and Exacta-Mix™ and MicroMacro™ Multi-Source Compounders; used worldwide in hospitals and healthcare facilities. Privately held, Baxa Corporation has subsidiaries and sales offices in Canada and the United Kingdom; direct representation in Austria, Belgium, Denmark, Finland, France, Germany, Luxembourg and The Netherlands; and distribution partners worldwide. Further information is available at http://www.baxa.com
About Clinical IQ
Founded in 1999, Clinical IQ, LLC, is a privately held consulting company based in Florham Park, New Jersey. It is led by Eric Kastango, MBA, RPh, FASHP, President and CEO, who is seen as an expert in many areas of the pharmacy industry, but particularly in USP Chapter 797 processes. Clinical IQ, LLC aims to serve as the trusted source for pharmacy information services and product solutions for all their customers who range from local start-up operations to established national companies in the hospital, home care, and specialty compounding industries. With this aim, Clinical IQ creates software, classroom training, web based training, audit tools, and many other informational products to make sterile compounding and related areas of pharmacy safer. Further information is available at http://www.clinicaliq.com
###
Contacts:
Marian Robinson, Vice President, Marketing
Baxa Corporation http://www.baxa.com 800.567.2292 ext. 2157 or 303.617.2157
Maggie Chamberlin Holben, APR
Absolutely Public Relations http://www.absolutelypr.com 303.984.9801 or 303.669.3558
Kastango is a Fellow of the American Society of Health-System Pharmacists and has served on the ASHP's Council of Education Affairs and as a pharmacy surveyor for the Accreditation Commission for Health Care, Inc. (ACHC). He travels across the United States to make professional presentations on a variety of pharmacy practice topics, including USP General Chapter 797 compliance, sterile preparation and pharmacy compounding errors, quality systems and collaborative pharmacy/nursing practice models. Kastango also is an elected member of the United States Pharmacopeia Council of Experts (Sterile Compounding Committee).
Kastango’s company Clinical IQ is a sponsor of the new state-of-the-art STAR (Skills Training, Academics and Resources) Center for pharmacy and cleanroom skills training on the Baxa Corporation campus. Baxa designed and built the STAR Center as a fully USP 797-compliant pharmacy cleanroom to provide professional education on pharmacy practice, cleanroom principles and compliance to regulatory requirements.
The STAR Center, the only dedicated facility of its kind in the world for hands-on cleanroom experience and training in environmental monitoring and aseptic technique, provides a unique opportunity for industry professionals to learn best practice from subject-matter expert trainers. More information is available at http://www.baxa.com/starcenter
On the subject of USP 797, Baxa Corporation has the technical paper, “Understanding USP 797,” available at http://www.publicrelationsnewsroom.com/_wsn/page4.html . In addition, the case study, “USP 797 Training Requirements,” is accessible at http://www.publicrelationsnewsroom.com/_wsn/page17.html
During the past year, Baxa Corporation and Kastango collaborated on the educational CD, 'What’s Next For USP 797?' – an educational CD produced as a public service for hospital pharmacists and administrators. Kastango’s presentation was originally recorded as a presentation to the annual American Society of Health-System Pharmacists (ASHP). The CD is aimed to help pharmacy directors and operational managers better understand the requirements for meeting the environmental controls outlined for sterile compounding under the new Chapter. It includes a discussion of current state for pharmacy compliance and the necessary next steps in moving from gap analysis to action plan for addressing the pharmacy changes to comply with USP 797.
A complimentary copy of the CD is available by calling 800.567.BAXA (2292) and submitting your name, title, organization affiliation and mailing address information.
Additional links of interest include:
Eric Kastango podcast about the educational CD:
http://301url.com/EricKPodcast
Link to ASHP Guidelines on Handling Hazardous Drugs: http://www.ashp.org/bestpractices/new/Haz_AJHP.pdf
About Baxa Corporation
Baxa, a customer-focused medical device company, provides innovative, solution-based technologies for fluid handling and delivery. Its systems and devices promote the safe and efficient preparation, handling, packaging, and administration of fluid medications. Key products include Rapid-Fill™ Automated Syringe Fillers, Exacta-Med® Oral Dispensers, MicroFuse® Syringe Infusers, Repeater™ Pharmacy Pumps, and Exacta-Mix™ and MicroMacro™ Multi-Source Compounders; used worldwide in hospitals and healthcare facilities. Privately held, Baxa Corporation has subsidiaries and sales offices in Canada and the United Kingdom; direct representation in Austria, Belgium, Denmark, Finland, France, Germany, Luxembourg and The Netherlands; and distribution partners worldwide. Further information is available at http://www.baxa.com
About Clinical IQ
Founded in 1999, Clinical IQ, LLC, is a privately held consulting company based in Florham Park, New Jersey. It is led by Eric Kastango, MBA, RPh, FASHP, President and CEO, who is seen as an expert in many areas of the pharmacy industry, but particularly in USP Chapter 797 processes. Clinical IQ, LLC aims to serve as the trusted source for pharmacy information services and product solutions for all their customers who range from local start-up operations to established national companies in the hospital, home care, and specialty compounding industries. With this aim, Clinical IQ creates software, classroom training, web based training, audit tools, and many other informational products to make sterile compounding and related areas of pharmacy safer. Further information is available at http://www.clinicaliq.com
###
Contacts:
Marian Robinson, Vice President, Marketing
Baxa Corporation http://www.baxa.com 800.567.2292 ext. 2157 or 303.617.2157
Maggie Chamberlin Holben, APR
Absolutely Public Relations http://www.absolutelypr.com 303.984.9801 or 303.669.3558
Contact
Baxa Corporation
Maggie Chamberlin Holben, APR
303.984.9801 or 303.669.3558
http://www.baxa.com
Maggie Chamberlin Holben, APR
303.984.9801 or 303.669.3558
http://www.baxa.com
Contact
Categories